Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetVivo HoldingsPETV -1.12%37 Equity-to-Asset is 0.51 as of Jun. 2026, which is 364% above its 10-year median of 0.11. GuruFocus rates PETV with a GF Score™ of 37/100 and a GF Value™ of $0.48 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 851 Medical Devices & Instruments companies, PetVivo Holdings ranks worse than 52.53% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PetVivo Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $1.36 Mil. PetVivo Holdings's Total Assets for the quarter that ended in Jun. 2026 was $2.67 Mil.
Therefore, PetVivo Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.51.
The historical rank and industry rank for PetVivo Holdings's Equity-to-Asset or its related term are showing as below:
PETV'
s Equity-to-Asset Range Over the Past 10 Years
Min: -7.11 Med: 0.11 Max: 0.86
Current: 0.51
During the past 13 years, the highest Equity to Asset Ratio of PetVivo Holdings was 0.86. The lowest was -7.11. And the median was 0.11.
PETV's Equity-to-Asset is ranked worse than 52.53% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs PETV: 0.51
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
PetVivo Holdings Equity-to-Asset Related Terms
PetVivo Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for PetVivo Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETV vs FOFA, ARAY, GTHP: Equity-to-Asset Comparison
For the Medical Devices subindustry, PetVivo Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
PetVivo Holdings's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (PETV) has a Equity-to-Asset of 0.51 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on PetVivo Holdings and its competitors. This is 364% above median its historical median of 0.11. According to the industry distribution chart, PetVivo Holdings ranks #447 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 52.5%.
Is PetVivo Holdings' Equity-to-Asset too high?
PetVivo Holdings' current Equity-to-Asset of 0.51 is 364% above median its 10-year median of 0.11. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. PetVivo Holdings' value of 0.51 is 20.3% below this industry median. Based on the distribution chart, PetVivo Holdings ranks #447 out of 851 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PetVivo Holdings has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PetVivo Holdings' Equity-to-Asset compare to FOFA and ARAY?
According to the Medical Devices & Instruments industry distribution chart, PetVivo Holdings ranks #447 out of 851 companies for Equity-to-Asset. This places PetVivo Holdings in the lower half of its industry. The industry median Equity-to-Asset is 0.64. PetVivo Holdings' value of 0.51 is 20.3% below this benchmark. While the company's 10-year median is 0.11 vs. the industry median of 0.64, PetVivo Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetVivo Holdings's current Equity-to-Asset of 0.51 is 20.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on PetVivo Holdings and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetVivo Holdings's current Equity-to-Asset is 0.51, which is 364% above median its own 10-year median of 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetVivo Holdings stock overvalued right now?
Based on GuruFocus' analysis, PetVivo Holdings (PETV) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.48, compared to a current price of $0.67 — trading 39.6% above its estimated fair value. The current Equity-to-Asset is 0.51, which is 364% above median its 10-year median of 0.11 and 20.3% below the Medical Devices & Instruments industry median of 0.64. PetVivo Holdings' overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For PetVivo Holdings (PETV), the current Equity-to-Asset is 0.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetVivo Holdings (PETV) Overvalued in 2026?
Based on GuruFocus' analysis, PetVivo Holdings stock appears to be overvalued.
The current stock price of $0.67 is trading 39.6% above its estimated GF Value™ of $0.48.
GuruFocus considers PetVivo Holdings to be Significantly Overvalued.
Key valuation signals for PETV:
Equity-to-Asset: 0.51 (364% above median its 10-year median of 0.11)
GF Value™: $0.48 vs. price of $0.67 (39.6% above fair value)
Industry Position: 20.3% below the Medical Devices & Instruments median (#447 of 851)
No single metric tells the full story. See the PETV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.
37GF Score
Get the complete analysis for PETV
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETV has been successfully added to your 
